Reishi Triterpenes vs. Polysaccharides: How They Differ

Reishi (Ganoderma lucidum)

495 triterpenoid compounds identified in Ganoderma species

Galappaththi et al. (2022, Biomolecules) catalogued 495 distinct triterpenoid compounds across 25 Ganoderma species, a scale of chemical complexity that exceeds virtually every other medicinal mushroom and explains why Reishi's bitter fraction has so many documented effects.

Galappaththi et al., Biomolecules, 2022

2 fractions

Reishi's polysaccharides and triterpenes act through completely different mechanisms on different cell targets

Dectin-1

the receptor through which beta-glucan polysaccharides activate immune cells

NF-kB

the inflammation master switch that triterpenes (ganoderic acids) suppress directly

Galappaththi et al., Biomolecules, 2022

View as image ↗

Reishi contains two major classes of bioactive compounds that work through mechanisms so different they could almost belong to separate medicines. The polysaccharides, primarily beta-glucans, activate the immune system. The triterpenes, primarily ganoderic acids, suppress inflammation and act directly on cancer cells. The two fractions do not reinforce each other through the same pathway; they address different biological problems through entirely separate molecular routes.

This matters practically because the two compound classes require different extraction solvents. Water captures polysaccharides. Alcohol captures triterpenes. A hot-water-only reishi extract delivers polysaccharides but no meaningful ganoderic acids. An alcohol-only extract delivers triterpenes but misses much of the polysaccharide fraction. This is the mechanistic basis for why dual extraction exists, and why understanding reishi triterpenes vs. polysaccharides is the essential first step to evaluating any Reishi product. For the complete Reishi overview, see what is Reishi mushroom: the science behind the mushroom of immortality.

The Solubility Difference That Determines Which Extraction You Need

The single most practical thing to understand about Reishi's two compound classes is their opposite relationship with water.

Polysaccharides are large chain-like molecules made of linked sugar units. Beta-glucans, the most pharmacologically active polysaccharides in Reishi, are water-soluble. They dissolve readily into hot water during extraction and can be captured, concentrated, and standardized in a water-based extract.

Triterpenes are built from a five-carbon building block called isoprene, assembled into ring structures through a biosynthetic pathway that starts with lanosterol (the same precursor used to make cholesterol). Ganoderic acids are lipid-soluble, which means they dissolve in fats and oils and in alcohol, but they do not dissolve in water. A hot-water extraction, regardless of duration or temperature within safe ranges, will not meaningfully extract ganoderic acids from Reishi fruiting body tissue.

Ahmad and colleagues documented in a 2021 comprehensive review that Reishi contains more than 400 bioactive compounds, with the lipid-soluble triterpene fraction and the water-soluble polysaccharide fraction representing complementary but mechanistically distinct systems.^[3] The review also noted that the triterpene fraction is specifically responsible for Reishi's characteristic bitter taste. This taste marker provides a rough quality signal: a bitter Reishi extract is likely to contain ganoderic acids; a mild or tasteless one probably does not, regardless of what the label claims.

How Polysaccharides Activate the Immune System

Beta-glucans do not directly kill bacteria, viruses, or cancer cells. They work by activating the immune cells that do the killing.

A 2005 mechanistic review by Lin established the foundational receptor-level distinction between Reishi's two fractions.^[1] Polysaccharides from Reishi activate innate immunity through two receptor systems: Dectin-1, a pattern-recognition receptor on the surface of macrophages, dendritic cells, and neutrophils; and toll-like receptors (TLRs), which are sensors that detect molecular patterns associated with pathogens and initiate immune responses.

When beta-glucans bind Dectin-1, they trigger a signaling cascade inside the immune cell that activates NF-kB (leading to cytokine production), turns on NK cell and macrophage killing programs, and initiates trained immunity: an epigenetic reprogramming that leaves immune cells in a state of enhanced readiness for subsequent challenges.

The polysaccharide action is fundamentally activation. The cells receiving the signal go from resting to alert. They produce more cytokines, more Natural Killer cell activity, more macrophage phagocytosis. This is why Reishi polysaccharides are described as immunostimulatory: they stimulate immune cells to do more of what they already do.

For more on beta-glucan immune activation mechanisms across medicinal mushrooms, see Reishi bioactive compounds: triterpenes, polysaccharides, and sterols.

How Triterpenes Suppress Inflammation Directly

Triterpenes work through the opposite principle: not activation, but suppression. And their primary target is a different molecule entirely.

Dudhgaonkar and colleagues tested isolated triterpene fractions from Ganoderma lucidum in macrophage cultures and measured the effect on two central inflammatory effectors.^[2] The triterpenes suppressed NF-kB activation (blocking the master switch that turns on inflammatory gene expression) and reduced COX-2 expression (COX-2 is the enzyme that produces prostaglandins, the signaling molecules responsible for inflammation, pain, and fever).

Critically, the study tested the triterpene fraction specifically isolated away from the polysaccharides. The anti-inflammatory effects were attributed specifically to the triterpene fraction. The polysaccharide fraction did not produce the same NF-kB and COX-2 suppression.

The Lin 2005 review confirmed this distinction in mechanistic terms:^[1] while polysaccharides activate immunity via Dectin-1 and TLRs (which paradoxically can involve NF-kB activation in the context of immune stimulation), the triterpene fraction acts through a different mode to suppress chronic inflammatory NF-kB activity at a different point in the pathway. The two fractions are not canceling each other out; they are modulating NF-kB in contextually different ways, one for acute immune activation and one for chronic inflammation suppression.

Ganoderic acids also inhibit HMG-CoA reductase, the enzyme responsible for cholesterol biosynthesis in the liver, which partially explains Reishi's documented lipid-lowering effects in clinical trials. This mechanism has no parallel in the polysaccharide fraction.

The Same Mushroom, Opposite Physiological Actions

Putting the two mechanisms together reveals something important about what Reishi actually does in the body.

Polysaccharides say "go": they activate immune cells, increase cytokine production, and prime the body for defense. Triterpenes say "calm down": they suppress the chronic inflammatory signals that would otherwise push the immune system into a damaging overactive state. In a whole Reishi product, these two fractions work in the same direction toward health but through physiological mechanisms that are genuinely opposite.

This is not a contradiction. Immune activation and inflammatory suppression address different aspects of immune dysregulation. Modern chronic disease often involves simultaneously an underactive adaptive immune response to cancer and infection and an overactive innate inflammatory state driving cardiovascular disease, metabolic disorders, and neurodegeneration. Reishi's polysaccharides address the first problem; its triterpenes address the second.

The 2024 Wang review confirmed this complementary picture, identifying 14 distinct biological activities of ganoderic acids across anti-cancer, anti-inflammatory, immunomodulation, anti-aging, hepatoprotective, neuroprotective, and cardiovascular domains.^[5] Each of these activities is rooted in triterpene mechanisms: HMG-CoA inhibition (lipid lowering), NF-kB suppression (anti-inflammatory), PI3K/AKT inhibition (anti-cancer), and cytokine modulation (immune calibration). None of these are mediated by the polysaccharide fraction.

The 2025 Ren review confirmed that both fractions contribute to cardiovascular, immune, and anti-cancer effects but through distinct pharmacological routes, and explicitly noted that dual extraction is necessary to capture both.^[6]

For a deeper look at what the pharmacology of the whole Reishi system looks like when both fractions are considered together, see the pharmacology of Ganoderma lucidum: how Reishi works.

The Scale of Reishi's Triterpene Complexity

One factor that distinguishes Reishi from other medicinal mushrooms is the sheer chemical complexity of its triterpene fraction.

Galappaththi and colleagues documented in a 2022 review that the Ganoderma genus contains 495 distinct triterpenoid compounds across 25 species.^[4] Ganoderma lucidum (red Reishi) contains the highest concentration of these compounds among commonly studied species. By comparison, most other medicinal mushrooms contain either no significant triterpenoids or a small number of relatively simple ones.

This chemical diversity explains the breadth of Reishi's documented effects. Different ganoderic acids target different molecular mechanisms: GA-A inhibits JAK2/STAT3 and PI3K/AKT; GA-DM triggers autophagy via PI3K/Akt/mTOR; GA-T induces mitochondrial apoptosis and modulates the tumor microenvironment; GA-D reverses cancer drug resistance via HIF-1alpha. A single extract from Reishi contains all of these acids simultaneously, producing a multi-target action that would require multiple pharmaceutical drugs to replicate.

This also explains why ganoderic acid research is complex: the compounds are not interchangeable. Studying "ganoderic acids" as a single entity misses the mechanistic diversity within the class. For a breakdown of the seven most-studied individual acids and their specific mechanisms, see ganoderic acid A, B, and beyond: individual compound research.

What Dual Extraction Actually Achieves

Given the different solubilities of the two fractions, dual extraction has a specific pharmacological rationale, not just a marketing one.

Zheng and colleagues optimized an ultrasonic-assisted extraction protocol that captured both polysaccharides and triterpenes from Ganoderma lucidum in a single step using ethanol mixed with water at a ratio of approximately 55-60% ethanol to 40-45% water.^[7] The mixed solvent simultaneously solubilized the lipid-soluble ganoderic acids and maintained enough water-polarity to capture the polysaccharides. The triterpenoid yield at this solvent ratio was significantly higher than with pure water and also higher than with pure ethanol, because some polarity assists in extracting the ganoderic acid fraction from the cell matrix.

More traditional dual extraction uses two separate steps: a hot-water step to capture polysaccharides, and an ethanol step to capture triterpenes, with the two fractions combined in the final product. Both approaches produce a product containing both compound classes.

A product labeled only for polysaccharides or only for beta-glucan percentage does not provide information about ganoderic acid content. A product that underwent hot-water extraction only contains no meaningful triterpenes regardless of other quality claims. For the complete practical guide to extraction methods and how to evaluate product quality based on what they capture, see ganoderic acid extraction methods: how processing affects potency.

For context on how dual extraction products compare to single-extract tinctures in the broader supplement category, see double-extraction tinctures: what makes them superior.

For a complete look at Reishi's ganoderic acid research in the cancer context, including the newest data on immunotherapy sensitization and drug resistance reversal, see ganoderic acids and cancer: specific anti-tumor research. For the overview of what ganoderic acids are as a compound class, see ganoderic acids: the unique triterpenes in Reishi.

The Bottom Line

Reishi's two major bioactive fractions have opposite solubilities and target different receptors. Polysaccharides (beta-glucans) are water-soluble and activate immune cells via Dectin-1 and toll-like receptors, turning on NK cell and macrophage programs. Triterpenes (ganoderic acids) are lipid-soluble and suppress chronic inflammatory NF-kB signaling and COX-2 activity, confirmed specifically in the triterpene fraction isolated from polysaccharides. Ganoderma species contain 495 identified triterpenoid compounds, more than any other commonly used medicinal mushroom. A water-only Reishi extract delivers polysaccharides but no ganoderic acids; alcohol is required for triterpene extraction. Dual extraction at approximately 55-60% ethanol in water achieves both fractions in a single step. Both fractions are pharmacologically active but through mechanisms too different to be covered by one product unless the product uses a dual extraction process.

Frequently Asked Questions

What is the difference between reishi polysaccharides and triterpenes?

Reishi polysaccharides (beta-glucans) are water-soluble compounds that activate immune cells by binding Dectin-1 and toll-like receptors, stimulating NK cells and macrophages. Reishi triterpenes (ganoderic acids) are lipid-soluble compounds that suppress chronic inflammation by blocking NF-kB and COX-2, and they target cancer cell pathways including JAK2/STAT3 and PI3K/AKT. The two fractions address different biological problems and require different extraction solvents.

Do you need to use alcohol to get reishi triterpenes?

Yes. Ganoderic acids are lipid-soluble and will not dissolve into water. A hot-water extraction, regardless of duration or temperature, captures polysaccharides effectively but yields almost no ganoderic acids. Extraction research found that approximately 55-60% ethanol mixed with water maximized combined recovery of both polysaccharides and triterpenes in a single step, with triterpenoid yield significantly higher than either pure water or pure ethanol alone.

Are beta-glucans or triterpenes more important in reishi?

They serve different purposes, so the question depends on the goal. For immune activation, enhanced NK cell activity, and trained immunity, the beta-glucan polysaccharide fraction is the primary active component. For chronic inflammation suppression, lipid lowering, and the cancer-related mechanisms (apoptosis, cell cycle arrest, anti-angiogenesis), the triterpene fraction is primary. A comprehensive Reishi product needs both; choosing one over the other reflects a specific therapeutic goal.

Why does reishi need dual extraction?

Because its two most pharmacologically active fractions have opposite solubilities. Beta-glucan polysaccharides dissolve in water; ganoderic acid triterpenes dissolve in alcohol. A single-solvent extraction misses one class entirely. Dual extraction uses both solvents, either sequentially (hot water step then ethanol step) or combined (a specific ethanol-water ratio), to capture both fractions in the final product.

Which reishi compounds are responsible for immune support vs anti-cancer effects?

Both fractions contribute to immune and anti-cancer activity, but through different mechanisms. Beta-glucan polysaccharides activate innate immune cells (NK cells, macrophages) via Dectin-1, which supports immune surveillance of cancer cells. Ganoderic acid triterpenes directly inhibit cancer cell proliferation through JAK2/STAT3, PI3K/AKT, and NF-kB pathways, trigger cancer cell death via apoptosis and autophagy, and suppress tumor angiogenesis (cutting off blood supply). The polysaccharide fraction is more relevant for immune support; the triterpene fraction contributes more specifically to the direct anti-cancer mechanisms.

Sources & References

1. 1RTHM-00084·Lin, Zhi-Bin (2005). “Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum..” Journal of pharmacological sciences.Study breakdown →PubMed →↩
2. 2RTHM-00152·Dudhgaonkar, Shailesh et al. (2009). “Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum..” International immunopharmacology.Study breakdown →PubMed →↩
3. 3RTHM-01321·Ahmad, Rizwan et al. (2021). “Ganoderma lucidum (Reishi) an edible mushroom; a comprehensive and critical review of its nutritional, cosmeceutical, mycochemical, pharmacological, clinical, and toxicological properties..” Phytotherapy research : PTR.Study breakdown →PubMed →↩
4. 4RTHM-01519·Galappaththi, Mahesh C A et al. (2022). “A Review of Ganoderma Triterpenoids and Their Bioactivities..” Biomolecules.Study breakdown →PubMed →↩
5. 5RTHM-02014·Wang, Siyi et al. (2024). “Research Progress on the Biological Activity of Ganoderic Acids in Ganoderma lucidum over the Last Five Years..” Life (Basel.Study breakdown →PubMed →↩
6. 6RTHM-02166·Ren, Sizhu et al. (2025). “A Review of Bioactive Components and Pharmacological Effects of Ganoderma lucidum..” Food science & nutrition.Study breakdown →PubMed →↩
7. 7RTHM-00668·Zheng, Shizhong et al. (2020). “Optimization of ultrasonic-assisted extraction of polysaccharides and triterpenoids from the medicinal mushroom Ganoderma lucidum and evaluation of their in vitro antioxidant capacities..” PloS one.Study breakdown →PubMed →↩